Combination of Hyperfractionated Radiotherapy With Immunotherapy in Massive Tumors
Clinical trial NCT04587817 · UNKNOWN
Trial details
- NCT number
- NCT04587817
- Sponsor
- Peking University First Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-15
- Primary completion
- 2022-09-19
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.